Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
MEDIROM Healthcare Technologies ( (MRM) ) just unveiled an announcement.
On March 13, 2025, MEDIROM Healthcare Technologies Inc. announced that Yasuhiro Hayami, Chief Business Officer of its subsidiary MEDIROM MOTHER Labs Inc., made a second investment in the Series A financing round at a pre-money valuation of JPY9 billion (approximately US$61 million). This investment underscores Mr. Hayami’s commitment to the company’s growth potential and aligns with MEDIROM’s corporate philosophy. The investment is expected to enhance the company’s market positioning and operational capabilities in the health-tech sector.
More about MEDIROM Healthcare Technologies
MEDIROM Healthcare Technologies Inc. operates in the health-tech sector, focusing on innovative health management solutions. Its subsidiary, MEDIROM MOTHER Labs Inc., offers products such as the ‘Specific Health Guidance Program’ through the ‘Lav’ health application and the 24/7 recharge-free MOTHER Bracelet smart tracker. These products cater to various industries, including caregiving, logistics, and manufacturing.
YTD Price Performance: -37.62%
Average Trading Volume: 68,529
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $3.16M
For a thorough assessment of MRM stock, go to TipRanks’ Stock Analysis page.